JOSEPH OBUBA: Open Payments
NPI 1043630627 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 23 payments from 8 companies in 2025. Trend: 2023 $1,069 · 2024 $591 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $180 |
| Janssen Pharmaceuticals, Inc | 4 | $144 |
| E.R. Squibb & Sons, L.L.C. | 1 | $129 |
| Teva Pharmaceuticals USA, Inc. | 2 | $115 |
| Lundbeck LLC | 6 | $106 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $15 |
Products named: FANAPT, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, UZEDY, INGREZZA, AUSTEDO XR, VRAYLAR.
Industry payments across GA — which companies pay providers there.
